UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi unveils two clinical trial results at EU conference
Hanmi Pharmaceutical said Tuesday that it has presented clinical trial resu...
by Lee Han-soo
|
2018-06-12 15:36
라인
What if South Korea supplies vaccines for North?
Under the reconciliatory atmosphere between South Korea and North Korea, a ...
by So Jae-hyeon
|
2018-06-12 15:36
라인
Risk of dementia jumps 29% for seniors with anesthesia experience
New research is showing that those over 50 years old who have undergone gen...
by Marian Chu
|
2018-06-12 15:32
라인
Obesity drugs marked poor sales in Q1
Most obesity treatments suffered sales declines in the first quarter, and p...
by So Jae-hyeon
|
2018-06-12 15:32
라인
UCB Korea withdraws epilepsy drug Vimpat
UCB Korea has taken Vimpat (ingredient: lacosamide) off the Korean market a...
by Marian Chu
|
2018-06-12 11:22
라인
Big Tobacco rebuts Seoul’s warning against heat-not-burn cigarettes
Philip Morris' IQOS and British American Tobacco's Glow Foreign t...
by Lee Han-soo
|
2018-06-12 11:19
라인
Dongkook, Chong Kun Dang most popular in functional foods
Dongkook Pharmaceutical, Chong Kung Dang Healthcare, and Sanofi-Aventis Kor...
by Nam Doo-hyun
|
2018-06-12 11:19
라인
Janssen Korea gets expanded indication for Zytiga
Janssen Korea said Tuesday it got the Ministry of Food and Drug Safety’s ap...
by Marian Chu
|
2018-06-12 11:01
라인
60 general hospitals use genetic therapy Invossa
Kolon Life Science and Mundipharma Korea said Invossa-K, a knee osteoarthri...
by So Jae-hyeon
|
2018-06-11 15:12
라인
Will Yervoy+Cemiplimab combo fight non-small cell lung cancer?
A global phase-2 clinical trial will soon take place in Korea to check if a...
by Lee Hye-seon
|
2018-06-11 15:11
라인
‘Aripiprazole improves awareness in schizophrenia patients’
Professors Kim Eui-tae (left) and Professor Kwon Jun-soo Researchers at S...
by Lee Han-soo
|
2018-06-11 15:10
라인
Lipiodol excluded from shortage prevention drugs
The Korean health authorities have excluded Guerbet Korea’s Lipiodol from “...
by Park Gi-taek
|
2018-06-11 11:30
라인
North Korean defector: I had reoccurring nightmares, like everyone else
She defected from North Korea 15 years ago, crossing over into China, Vietn...
by Marian Chu
|
2018-06-11 11:01
라인
SNUH, HongCi sign strategic partnership agreement
SNUH President and CEO Suh Chang-suk (center) and HongCi Healthcare Group C...
by Lee Han-soo
|
2018-06-11 10:59
라인
Celgene Korea gets 3 more indications for Revlimid
Celgene Korea said Monday that it has got three additional indications for ...
by Marian Chu
|
2018-06-11 10:59
라인
‘Substance derived from squash effective in treating osteoporosis’
Viromed said Thursday that it has published research regarding dehydrodicon...
by Lee Han-soo
|
2018-06-08 18:28
라인
Medical students support lifting abortion ban
Medical school students in Korea announced that they supported a recent pet...
by Lee Min-ju
|
2018-06-08 16:27
라인
Multinationals dominated drug sales in Q1 -- again
Multinational pharmaceutical firms led local drug sales in the first quarte...
by So Jae-hyeon
|
2018-06-08 16:22
라인
JW wins patent for cancer diagnosis technology in Japan
JW Holdings said Thursday that the Japan Patent Office has approved its pat...
by Lee Han-soo
|
2018-06-08 14:58
라인
Cancer survivors at higher risk of diabetes: study
Although the advent of new anticancer drugs and cutting-edge treatment has ...
by Marian Chu
|
2018-06-08 14:57
-
이전
201
202
203
204
205
206
207
208
209
210
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top